Cardinal Health (NYSE: CAH) Reports Before The Bell – What Are Markets Expecting?

Cardinal Health (NYSE: CAH), a prominent player in the healthcare services and products industry, is expected to report earnings before today's market open. With an earnings consensus at $1.73 per share on revenues of $58.63BN, investors are watching closely as the company prepares to deliver its financial results.

CAH stock has been taking a breath in the pre-market ahead of results, after impressive gains of 1.91% on the New York Stock Exchange yesterday. On a YTD basis, the stock price finds itself back almost exactly where it began. So what is going on at Cardinal Health?

Cardinal Health, based in Dublin, Ohio, operates as a healthcare services and products company with global reach, including markets like the United States, Canada, Europe, and Asia. The company, established in 1979, is divided into two main segments, Pharmaceutical and Medical.

The Pharmaceutical segment is involved in the distribution of pharmaceutical and consumer products, in addition to other related services. The Medical segment, on the other hand, oversees the production and distribution of various medical and surgical supplies, including a comprehensive assortment of laboratory products.

Cardinal Health boasts a market capitalization of approximately $24.78 billion and has traded within a 52-week range between $85.12 and $116.04.

Financially, Cardinal Health previously reported total revenue exceeding $220 billion, with net income attributable to common shareholders at $552 million.

Investors have also reflected on Cardinal Health's valuation metrics, with a trailing P/E ratio currently at 45.02 and a forward P/E estimate of 13.51. The company offers a dividend rate of $2.02, yielding around 2.01%, and has a payout ratio of approximately 88.6%.

Analysts have set a mean target price for the stock at $113.08, with a consensus recommendation standing at “buy.” Among the analysts covering Cardinal Health, the average recommendation score is 2.4, reflecting a general optimism that aligns with the 15 opinions contributing to this mean figure.

Cardinal Health continues to maintain its strong position within the Medical Distribution industry as part of the larger Healthcare sector. With its extensive business operations and comprehensive product lines, Cardinal Health is poised to remain a significant entity in its field, drawing continued interest as it approaches its earnings report.